Navigation Links
Decongestant in OTC Cold Remedies Effective: FDA Panel
Date:12/14/2007

d we are committed to working with FDA to ensure that the scientific data further supports this goal."

CHPA's members include Bayer, GlaxoSmithKline, Perrigo and most other makers of over-the-counter medicines, according to the AP.

The issue had been brought to the FDA by University of Florida researchers whose review of 14 studies on phenylephrine suggested that pill and syrup versions of these medicines offered users no real relief. The researchers had petitioned the FDA to investigate the matter and also examine the possibility of requiring higher doses that would work.

Drug companies have recently turned to phenylephrine as a replacement for another decongestant, pseudoephedrine, to comply with a 2006 U.S. law requiring that products containing pseudoephedrine be sold from behind the counter. The law was designed to prevent these medications from being bought in bulk and turned into methamphetamine.

On the academics' side, according to the AP, was drug maker Schering-Plough, which had decided not to reformulate its Claritin line of decongestants, which contain pseudoephedrine.

"If you have a stuffy nose, and you take an over-the-counter product containing phenylephrine, you will still not be able to breathe through your nose after you take it. That's the bottom line," Leslie Hendeles, a professor of pharmacy and pediatrics at the University of Florida, contended before the advisers met.

Hendeles had led the review, which was published in the July 2006 issue of the Journal of Allergy and Clinical Immunology, and he had petitioned the FDA to boost the maximum allowable dose of phenylephrine in oral decongestants to 25 milligrams, which he believes may be more effective.

"There needs to be a dose-response study where you look a 10-, 25- and 50-milligram doses and determine what dose would give you a relief of your stuffy nose without side effects," he said.

But one
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Amneal Pharmaceuticals & Indoco Remedies Finalize Long Term Joint Venture Agreement to Develop and Market Generic Ophthalmic Pharmaceuticals
2. Internet remedies for STIs pose significant public health hazard
3. Internists Diagnose Health Care System Ills, Prescribe Remedies to Achieve Universal Coverage, Better Quality, and Lower Costs
4. FDA Mulls Effectiveness of OTC Cold Remedies
5. FDA Panel Finds OTC Cold Remedies Effective
6. Virginia Tech Review Panel Calls For Reform of Mental Health Treatment Law
7. CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation
8. Patient Safety Authority Board of Directors Names Infection Advisory Panel
9. Partners Rx Chief Pharmacy Officer, Richard Bullard on Panel Discussion at the Fall 2007 Managed Markets Summit (MMS) in Phoenix, AZ.
10. Billians HealthDATA GM Speaking on Dreamforce 07 Panel
11. FDA Panel Recommends Approval of SyntheMeds REPEL-CV(R) Adhesion Barrier for Pediatric Patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Decongestant in OTC Cold Remedies Effective: FDA Panel
Decongestant in OTC Cold Remedies Effective: FDA Panel
(Date:9/5/2008)...s the Latest Developments in Molecular,Testing and... /PRNewswire-USNewswire/ -- The practice of,pathol...g and the promise,of personalized medicine will ch...and other imaging technologies will change the way...ogists is taking a leadership role in,making sure ...
(Date:9/5/2008)...RNewswire-USNewswire/ -- The Health Resources,and ... million in grants to,increase and improve medical... grants continue President Bush,s historic expansi...w reach more economically,vulnerable and geographi...dministrator Elizabeth M. Duke said. "In 2007, mor...
(Date:9/5/2008)...tical ,anti-cloak, could bring objects out of hidi...-- Just in case someone develops a cloak of invisi... how to uncloak the objects it hides. , Accordi...in materials underneath an invisibility cloak woul...esearchers at Shanghai Jiao Tong University in Chi...
(Date:9/5/2008)...ain to commit to develop a National AIDS,Strategy ...p. 5 /PRNewswire-USNewswire/ -- The,Republican Nat...ion of the,domestic AIDS epidemic in the United St...erseas. Neither Presidential nominee Sen. John McC... mentioned AIDS in their remarks,to Convention del...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3
...he UK say that wound healing in depressed people i...ese and related reports find a place in the latest...sychological factors could have direct and indirec... according to the researchers. Depression and othe...
...eefe of Duke University Medical School in Durham, ...er in April issue of the Journal of pain. Patients... chronic pain of rheumatoid arthritis can reduce t...being, the researchers say. Dr. Francis says, "One...
...that exercising reduces the risk of heart disease.... for obese and fat people. But recent study shows ...art diseases because fitness and fatness are both ...ous heart ailments. Dr. Peter T. Katzmarzyk of Yor...
...just a year old, which was developed to fight resi...acteria are showing signs of resistance. The drug .... faecium) infections that are resistant to the ol...e has been that the new drug would help tackle the...
Other Medicine News:
(Date:9/5/2008)...t. 5 /PRNewswire-USNewswire/ -- A team of,research.... immigrants from,India and Pakistan take on the h...isks of prostate cancer among male immigrants and ...prostate cancer develop due to many reasons, but,e...le in these cancers,",said Jame Abraham, M.D., med...
(Date:9/4/2008)...qMan(R) real-time PCR testing for the diagnostic ...Calif., Sept. 4 /- The U.S. Food & Dr...AS(R) TaqMan(R) HBV Test,the first assay for quan....,The test uses Roche,s real-time PCR technology t...a patient,s blood. Doctors may use viral load,test...
(Date:9/4/2008)...eptember 4 /- Axentis Pharma AG has,i...safety and tolerability,of a new therapeutic formu...tion in cystic fibrosis patients. The new formulat...delivered directly to the site of,infection. The f...two,different doses of the new drug. Initial resul...
(Date:9/3/2008)...t. 4 /Xinhua--,Pharmaceutic...y announced,that it has enrolled the first subject...aluating Bronchitol in cystic fibrosis sufferers.,...tals across North,America, Argentina and Germany, ...eks approval to market Bronchitol for cystic fibro...
Breaking Medicine Technology:Immigrants From India, Pakistan Face U.S. Prostate, Breast Cancer Risks 2FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 2Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 3Wild American Shrimp Board Agrees To Implement New Self Funding Measures 2952 1Wild American Shrimp Board Agrees To Implement New Self Funding Measures 2952 2Shires ELAPRASE 28R 29 28idursulfase 29 Approved in Japan for the Treatment of Hunter Syndrome 1079 1Shires ELAPRASE 28R 29 28idursulfase 29 Approved in Japan for the Treatment of Hunter Syndrome 1079 2Shires ELAPRASE 28R 29 28idursulfase 29 Approved in Japan for the Treatment of Hunter Syndrome 1079 3Shires ELAPRASE 28R 29 28idursulfase 29 Approved in Japan for the Treatment of Hunter Syndrome 1079 4Genzyme Receives Approval to Market Elaprase 28R 29 in Japan 1075 1Genzyme Receives Approval to Market Elaprase 28R 29 in Japan 1075 2Genzyme Receives Approval to Market Elaprase 28R 29 in Japan 1075 3Genzyme Receives Approval to Market Elaprase 28R 29 in Japan 1075 4 244 million nursing grant focuses on at risk premature infants 2948 1 244 million nursing grant focuses on at risk premature infants 2948 2
...ical Data Published at the American,Society of Cli...04, 2007 /PRNewswire-FirstCall/ -- Pharmion,Corpor...se II,multi-center clinical study of Amrubicin, t...ine currently in development,for the treatment of ...vorable interim results in terms of response rate ...
...h Follicular Lymphoma Reported,Today at ASCO Annua.../ -- GlaxoSmithKline plc,announced today long-term...ne-week course of frontline treatment with the BEX... I-131 Tositumomab) in,76 patients with newly diag...NHL). This regimen was found to induce durable cli...
Other Medicine Technology:Pharmion's Amrubicin Shows Encouraging Results Compared to Standard,of Care in Second Line Treatment of Small Cell Lung Cancer 2Pharmion's Amrubicin Shows Encouraging Results Compared to Standard,of Care in Second Line Treatment of Small Cell Lung Cancer 3Pharmion's Amrubicin Shows Encouraging Results Compared to Standard,of Care in Second Line Treatment of Small Cell Lung Cancer 48-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 28-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 38-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 48-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 58-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 68-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 7
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
Medicine Products: